Aperio Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $91K | Sell |
18,924
-32,087
| -63% | -$154K | ﹤0.01% | 2384 |
|
|
2020
Q3 | $297K | Buy |
51,011
+32,241
| +172% | +$188K | ﹤0.01% | 2073 |
|
|
2020
Q2 | $127K | Buy |
18,770
+1,521
| +9% | +$10.3K | ﹤0.01% | 2254 |
|
|
2020
Q1 | $110K | Buy |
+17,249
| New | +$110K | ﹤0.01% | 2209 |
|
|
2019
Q3 | – | Sell |
-3,235
| Closed | -$48K | – | 2885 |
|
|
2019
Q2 | $48K | Buy |
+3,235
| New | +$48K | ﹤0.01% | 2544 |
|
|
2018
Q2 | – | Sell |
-5,060
| Closed | -$267K | – | 2292 |
|
|
2018
Q1 | $267K | Sell |
5,060
-13
| -0.3% | -$686 | ﹤0.01% | 2012 |
|
|
2017
Q4 | $345K | Sell |
5,073
-188
| -4% | -$12.8K | ﹤0.01% | 1875 |
|
|
2017
Q3 | $434K | Buy |
5,261
+168
| +3% | +$13.9K | ﹤0.01% | 1728 |
|
|
2017
Q2 | $477K | Buy |
5,093
+83
| +2% | +$7.77K | ﹤0.01% | 1682 |
|
|
2017
Q1 | $319K | Buy |
+5,010
| New | +$319K | ﹤0.01% | 1794 |
|
|
2015
Q4 | – | Sell |
-3,127
| Closed | -$288K | – | 2030 |
|
|
2015
Q3 | $288K | Buy |
3,127
+276
| +10% | +$25.4K | ﹤0.01% | 1582 |
|
|
2015
Q2 | $251K | Sell |
2,851
-61
| -2% | -$5.37K | ﹤0.01% | 1740 |
|
|
2015
Q1 | $216K | Buy |
+2,912
| New | +$216K | ﹤0.01% | 1786 |
|